Reuters logo
BRIEF-Lonza to acquire Capsugel for $5.5 bln
December 15, 2016 / 5:43 AM / a year ago

BRIEF-Lonza to acquire Capsugel for $5.5 bln

Dec 15 (Reuters) - Lonza Group Ag

* Lonza to acquire Capsugel to create leading integrated solutions provider to the global pharma and consumer healthcare industries

* Says to acquire Capsugel for $5.5 billion

* Says transaction is expected to be core EPS accretive in first full year post closing

* Says expects to achieve CHF 30 million p.a. operating synergies and CHF 15 million tax synergies per annum by year three

* Says intends to retain current dividend policy and maintain about 3x net debt/EBITDA leverage

* Says deal includes refinancing of existing Capsugel debt of approximately $2 billion

* Says has committed debt financing for full acquisition amount from BofA Merrill lynch and UBS and plans to raise equity

* Says financial package foresees refinancing of Lonza’s current CHF 700 million revolving credit facility

* Says all-cash acquisition of Capsugel will be financed with a combination of debt and equity financing Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below